Rebecca Berger


Rebecca Berger is currently a Director in the Global Regulatory Affairs CMC Biologics group at Sanofi. Rebecca has worked in Sanofi since 2009, when she joined Genzyme and moved from the UK to Boston, MA. Prior to that Rebecca worked at GlaxoSmithKline in Global Post Approval CMC Regulatory. Rebecca has worked on multiple aspects of small molecule and biologics regulatory during her time in CMC Regulatory affairs. She has supported development molecules and commercial products. Prior to regulatory, Rebecca had experiences within pharma in both Drug Metabolism and in Immunology Research. Rebecca has a BSc in Biochemistry from the University of Warwick, UK and a PhD in Biochemistry from the University of Cambridge, UK.